Factors Associated with the Use of Highly Active Antiretroviral Therapy in Patients Newly Entering Care in an Urban Clinic
- 1 April 2003
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 32 (4) , 399-405
- https://doi.org/10.1097/00126334-200304010-00009
Abstract
Ethnic minority, female, and drug-using patients may be less likely to receive highly active antiretroviral therapy (HAART), despite its proven benefits. We reviewed the medical records of a consecutive population of 354 patients entering care in 1998 at the Thomas Street Clinic, an academically affiliated, public, HIV-specialty clinic in Houston, to determine the factors associated with not receiving HAART as recorded in pharmacy records. Ninety-two patients (26.0%) did not receive HAART during at least 6 months of follow-up. Patients who did not receive HAART were more likely to be women and to have missed more than two physician appointments and were less likely to have a CD4 count 5Keywords
This publication has 32 references indexed in Scilit:
- Use of Highly Active Antiretroviral Therapy in a Cohort of HIV-Seropositive WomenAmerican Journal of Public Health, 2002
- Predictors of Use of Highly Active Antiretroviral Therapy (HAART) Among Persons With AIDS in San Francisco, 1996–1999JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Trends in Prescriptions for Highly Active Antiretroviral Therapy in Four New York City HIV ClinicsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Intravenous Drug Use, Relationship With Providers, and Stage of HIV Disease Influence the Prescription Rates of Protease InhibitorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- A Comparison of Exposure Groups in the EuroSIDA Study: Starting Highly Active Antiretroviral Therapy (HAART), Response to HAART, and SurvivalJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Delays in protease inhibitor use in clinical practiceJournal of General Internal Medicine, 1999
- Variations in the Care of HIV-Infected Adults in the United StatesPublished by American Medical Association (AMA) ,1999
- Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection DurationJAMA, 1998
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998